Daniel H. Ahn

6.1k citations
153 papers · 3.7k indexed · 1 hit paper · h-index 31

Daniel H. Ahn

141 papers receiving 3.7k citations

Hit Papers

Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatm...3212019202620212023100200300

Peers

Daniel H. Ahn
Comparison fields: 5 of 98
  • Oncology 2.0k
  • Hepatology 283
  • Cancer Research 527
  • Surgery 1.5k
  • Pathology and Forensic Medicine 520
Replace Satoru Iwasa with:
Satoru Iwasa Japan
Jean‐Christophe Sabourin France
Chang Ohk Sung South Korea
Brian G. Czito United States
Guido Lammering Netherlands
Takahiro Hasebe Japan
Renata Ferrarotto United States
Maximilian Bockhorn Germany
Antonio Avallone Italy
Salah‐Eddin Al‐Batran Germany
Daniel H. Ahn relative to Satoru Iwasa Japan Satoru Iwasa's profile →
Citations per field
00.5×1.7×
Satoru Iwasa · 1×
Citations per year

Countries citing papers authored by Daniel H. Ahn

Since Specialization
Citations

This map shows the geographic impact of Daniel H. Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel H. Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel H. Ahn more than expected).

Fields of papers citing papers by Daniel H. Ahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel H. Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel H. Ahn. The network helps show where Daniel H. Ahn may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniel H. Ahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel H. Ahn Line = papers co-authored together Daniel H. Ahn links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20250
3 20250
4 20255
5 20240
6 20241
7 202411
8 20236
9 20233
10 20231
11 20231
12 202210
13 20221
14 20215
15 201931
16 201954
17 201820
18 201723
19 201569
20 2015100

About Daniel H. Ahn

Daniel H. Ahn is a scholar working on Oncology, Cancer Research and Surgery, having authored 153 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (48 papers), Pancreatic and Hepatic Oncology Research (45 papers), Colorectal Cancer Treatments and Studies (41 papers), Cancer Genomics and Diagnostics (33 papers), Cancer Treatment and Pharmacology (17 papers), Genetic factors in colorectal cancer (14 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Gallbladder and Bile Duct Disorders (12 papers). The work is most often cited by research in Oncology (2.0k citations), Hepatology (283 citations) and Cancer Research (527 citations). Daniel H. Ahn has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Tanios Bekaii‐Saab, Stanley Lu, Glyn Johnson, Mitesh J. Borad, Soonmee Cha, Milind Javle, Rachna T. Shroff, Ahmed O. Kaseb, Mohamad Bassam Sonbol and Meng Law. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, Annals of Oncology, Cancers and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026